Johnson & Johnson plans to launch largest-ever coronavirus vaccine trial with up to 60,000 people
Johnson & Johnson is planning to start a late-stage clinical trial of its experimental coronavirus vaccine in up to 60,000 people worldwide in late September. If the company hits the enrollment aim, which was reported on a US government database, it would be the largest-ever study looking at a possible immunization for the virus. Rival … Read more